Is IKNA or DGRO a better dividend investment in 2026?

IKNA currently yields 11.66% with a 5% 5-year dividend growth rate. DGRO yields 2.10% with 9.5% growth. The better choice depends on your goal: IKNA offers higher current income.

What is the dividend yield difference between IKNA and DGRO?

IKNA has a forward dividend yield of 11.66% ($2.00/share annually). DGRO yields 2.10% ($1.47/share annually). The yield gap is 9.56 percentage points.

Home › Compare › IKNA vs DGRO

IKNA vs DGRO: Dividend Comparison 2026

IKNA yields 11.66% · DGRO yields 2.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IKNA wins by $11.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

IKNA

● Live price

11.66%

Share price

$17.16

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43.2K

Annual income

$2,414.13

Full IKNA calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.10%

Share price

$70.18

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$235.38

Full DGRO calculator →

Portfolio growth — IKNA vs DGRO

📍 IKNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IKNA	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IKNA + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IKNA pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IKNA

Annual income on $10K today (after 15% tax)

$990.68/yr

After 10yr DRIP, annual income (after tax)

$2,052.01/yr

DGRO

Annual income on $10K today (after 15% tax)

$178.14/yr

After 10yr DRIP, annual income (after tax)

$200.07/yr

At 15% tax rate, IKNA beats the other by $1,851.94/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IKNA + DGRO for your $10,000?

IKNA: 50%DGRO: 50%

100% DGRO50/50100% IKNA

Portfolio after 10yr

$37.4K

Annual income

$1,324.75/yr

Blended yield

3.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on IKNA right now

IKNA

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$1.33

-92.2% upside vs current

Range: $1.33 — $1.33

Altman Z

60.4

Piotroski

2/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IKNA buys

DGRO buys

No recent congressional trades found for IKNA or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIKNADGRO

Forward yield	11.66% ✓	2.10%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$43.2K ✓	$31.6K
Annual income after 10y	$2,414.13 ✓	$235.38
Total dividends collected	$17.8K ✓	$2.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IKNA vs DGRO ($10,000, DRIP)

Year	IKNA Portfolio	IKNA Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$11,866	$1,165.50	$11,290	$209.57	+$576.00 → IKNA
2	$13,989	$1,292.45	$12,722	$213.54	+$1.3K → IKNA
3	$16,392	$1,424.02	$14,314	$217.18	+$2.1K → IKNA
4	$19,099	$1,559.51	$16,080	$220.53	+$3.0K → IKNA
5	$22,134	$1,698.17	$18,040	$223.59	+$4.1K → IKNA
6	$25,522	$1,839.29	$20,215	$226.40	+$5.3K → IKNA
7	$29,291	$1,982.13	$22,627	$228.96	+$6.7K → IKNA
8	$33,467	$2,125.99	$25,302	$231.31	+$8.2K → IKNA
9	$38,080	$2,270.21	$28,268	$233.44	+$9.8K → IKNA
10	$43,160	$2,414.13	$31,557	$235.38	+$11.6K → IKNA

IKNA vs DGRO: Complete Analysis 2026

IKNA — Stock

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Full IKNA Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this IKNA vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IKNA vs SCHD IKNA vs JEPI IKNA vs O IKNA vs KO IKNA vs MAIN IKNA vs VIG IKNA vs NOBL IKNA vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.